Table 1. Comparison between Control, CRCRTR-MACE <10% and CRCRTR-MACE ≥20%.

Marker	Control	MACE < 10%	MACE ≥ 20%	P1	P2	P3	P4
IL6	6.53pg/mL(0.08–58.98)	6.36 pg/mL (0.3–139.31)	9.63 pg/mL (0.3–167.58)	0.140	0.490	0.036	0.134
IL8	8.7 pg/mL (0.08–42.28)	11.95 pg/mL (2.85–103.21)	13.52 pg/mL (3.7–495.97)	0.046	0.088	0.049	0.348
IL9	18.37 pg/mL (0.65–71.8)	23.46 pg/mL (1.72–357.38)	25.11 pg/mL (5.99–165.57)	0.108	0.109	0.033	0.328
IL15	2.5 pg/mL (0.59–25.1)	5.2 pg/mL (1.52–20.01)	4.09 pg/mL (1.52–42.79)	0.012	0.003	0.010	0.784
IL16	64.22 pg/mL (5.16–527.73)	88.54 pg/mL (20.57–720.69)	75.28 pg/mL (9.77–392.43)	0.410	0.018	0.114	0.571
IL17	31.74 pg/mL (0.09–126.13)	37.46 pg/mL (0.09–167.3)	46.55±27.00 pg/mL	0.250	0.240	0.042	0.451
IL20	62.48 pg/mL (18.71–528.16)	195.02 pg/mL (48.8–844.45)	75.05 pg/mL (48.8–806.74)	0.001	0.001	0.032	0.419
IL21	17.37 pg/mL (3.27–30.92)	19.53 pg/mL (3.8–39.74)	19.53 pg/mL (3.21–30.18)	0.004	0.002	0.031	0.809
IL33	19.53 pg/mL (0.14–150.91)	19.53 pg/mL (0.14–53.75)	32.37 pg/mL (0.14–337.65)	0.000	0.108	0.002	0.005
IFN-γ	71.54 pg/mL (0.07–2886.64)	67.5 pg/mL (0.07–1818.3)	102.62 pg/mL (0.07–1432.36)	0.003	0.288	0.637	0.279

P1 is the p value between the three groups: control, CRCRTR-MACE <10% and CRCRTR-MACE ≥20%, (P1 was computed by one-way ANOVA); P2 is the p value between control and CRCRTR-MACE <10%; P3 is the p value between control and CRCRTR-MACE ≥20%; P4 is the p value between CRCRTR-MACE <10% and CRCRTR-MACE ≥20% (P2,P3&P4 were computed by Mann-Whitney U-test).

Note the following interleukins were not significant in the analysis: IL1a, IL1b, IL2, IL4, IL5, IL7, IL10, IL12p70, IL13, IL23, IL23A, TNF-α (full results shown in appendix 1)